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Introduction {#bjs538-sec-0005}
============

The clinical management of intraductal papillary mucinous neoplasia (IPMN) is still controversial. The major reason is the absence of factors that clearly predict malignancy. To overcome this issue, consensus conferences in Sendai[1](#bjs538-bib-0001){ref-type="ref"} and Fukuoka[2](#bjs538-bib-0002){ref-type="ref"} have defined combinations of risk factors that may predict malignancy more sensitively and specifically. A large number of mainly single‐centre analyses based on these criteria have been published, but a recent meta‐analysis[3](#bjs538-bib-0003){ref-type="ref"} of data from these publications demonstrated that both overall sensitivity and specificity of the most recent (Fukuoka) criteria were relatively low.

The present study aimed to assess the predictive values of individual factors that have been associated with malignancy in IPMN. Studies including branch duct (BD), main duct (MD) and mixed‐type IPMN were considered, focusing on those that reported sensitivity and specificity of individual risk factors of malignancy. Data were pooled and meta‐analysed, allowing for a determination of statistical classifiers.

Methods {#bjs538-sec-0006}
=======

The Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) guidelines[4](#bjs538-bib-0004){ref-type="ref"} were followed. Two investigators screened two databases, PubMed and Web of Science, independently. In cases of disagreement, a third investigator decided on inclusion of the study. The search strategy consisted of the following terms: 'intraductal papillary mucinous neoplasm' AND biomarker OR marker OR predictor OR malignancy OR serum OR CA19‐9 OR CEA OR 'pancreatic enzymes' OR amylase OR lipase OR PLR OR NLR OR Ca24‐2 OR bilirubin OR platelet OR neutrophil and 'pancreatic cancer' AND enzymes OR 'serum amylase' OR 'serum lipase' OR amylase OR lipase OR 'serum enzymes' and 'cancer AND platelet lymphocyte ratio OR neutrophil lymphocyte ratio'. The search was conducted to cover articles published between 2006 (publication of the Sendai consensus) and April 2016 (date of search).

Criteria for study inclusion were as follows: patients with histologically confirmed IPMN; studies that analysed one or more of the factors of the consensus guidelines or one of the other factors defined in the primary literature search; and studies that allowed for clear assignment of presence of the respective factor to the histological outcome. Invasive carcinoma and high‐grade dysplasia (formerly carcinoma in situ) were considered as malignant lesions.

Articles with abstracts that did not fit the scope of the search were excluded, along with non‐English‐language articles, case reports, small case series with ten or fewer patients, reviews and meta‐analyses. Only studies that allowed for a quantitative analysis of the results into a 2 × 2 contingency table were included in the meta‐analysis.

Studies eligible for inclusion were grouped according to the respective factor of interest. All continuous exposures (for example laboratory parameters such as carbohydrate antigen (CA) 19‐9) were then converted into a binary form using widely used cut‐off values. In the next step, 2 × 2 tables were designed for all studies. Sensitivities, specificities, negative predictive values (NPVs), positive predictive values (PPVs) and diagnostic odds ratios (DORs) were calculated. Results were pooled using a random‐effects model. Final results for each analysed factor were depicted using forest plots. Heterogeneity was assessed using I ^2^ statistics. Study quality and publication bias were investigated using funnel plots. The open‐source statistical software R 3.3 and the meta‐analysis package metafor 1.9‐9 (R Foundation for Statistical Computing, Vienna, Austria) were used for the analysis. The mada 0·5·7 package was used for calculation of the hierarchical summary receiver operating characteristic (HSROC) curves and the corresponding area under the curve (AUC).

Results {#bjs538-sec-0007}
=======

A total of 3443 studies were screened. Initial screening for markers derived from the differential blood count (neutrophil : lymphocyte ratio, platelet : lymphocyte ratio) revealed poor study quality for these factors, so these studies were excluded. After further exclusion of non‐relevant studies, 60 were included in the final analysis (Fig.  [1](#bjs538-fig-0001){ref-type="fig"}). Of these studies, 33 investigated mural nodules[5](#bjs538-bib-0005){ref-type="ref"}, [6](#bjs538-bib-0006){ref-type="ref"}, [7](#bjs538-bib-0007){ref-type="ref"}, [8](#bjs538-bib-0008){ref-type="ref"}, [9](#bjs538-bib-0009){ref-type="ref"}, [10](#bjs538-bib-0010){ref-type="ref"}, [11](#bjs538-bib-0011){ref-type="ref"}, [12](#bjs538-bib-0012){ref-type="ref"}, [13](#bjs538-bib-0013){ref-type="ref"}, [14](#bjs538-bib-0014){ref-type="ref"}, [15](#bjs538-bib-0015){ref-type="ref"}, [16](#bjs538-bib-0016){ref-type="ref"}, [17](#bjs538-bib-0017){ref-type="ref"}, [18](#bjs538-bib-0018){ref-type="ref"}, [19](#bjs538-bib-0019){ref-type="ref"}, [20](#bjs538-bib-0020){ref-type="ref"}, [21](#bjs538-bib-0021){ref-type="ref"}, [22](#bjs538-bib-0022){ref-type="ref"}, [23](#bjs538-bib-0023){ref-type="ref"}, [24](#bjs538-bib-0024){ref-type="ref"}, [25](#bjs538-bib-0025){ref-type="ref"}, [26](#bjs538-bib-0026){ref-type="ref"}, [27](#bjs538-bib-0027){ref-type="ref"}, [28](#bjs538-bib-0028){ref-type="ref"}, [29](#bjs538-bib-0029){ref-type="ref"}, [30](#bjs538-bib-0030){ref-type="ref"}, [31](#bjs538-bib-0031){ref-type="ref"}, [32](#bjs538-bib-0032){ref-type="ref"}, [33](#bjs538-bib-0033){ref-type="ref"}, [34](#bjs538-bib-0034){ref-type="ref"}, [35](#bjs538-bib-0035){ref-type="ref"}, [36](#bjs538-bib-0036){ref-type="ref"}, [37](#bjs538-bib-0037){ref-type="ref"}, 21 examined dilatation of the main pancreatic duct (MPD)[7](#bjs538-bib-0007){ref-type="ref"} [9](#bjs538-bib-0009){ref-type="ref"}, [15](#bjs538-bib-0015){ref-type="ref"} [16](#bjs538-bib-0016){ref-type="ref"}, [18](#bjs538-bib-0018){ref-type="ref"} [21](#bjs538-bib-0021){ref-type="ref"}, [23](#bjs538-bib-0023){ref-type="ref"} [26](#bjs538-bib-0026){ref-type="ref"}, [27](#bjs538-bib-0027){ref-type="ref"} [30](#bjs538-bib-0030){ref-type="ref"}, [32](#bjs538-bib-0032){ref-type="ref"} [36](#bjs538-bib-0036){ref-type="ref"}, [38](#bjs538-bib-0038){ref-type="ref"}, [39](#bjs538-bib-0039){ref-type="ref"}, [40](#bjs538-bib-0040){ref-type="ref"}, [41](#bjs538-bib-0041){ref-type="ref"}, [42](#bjs538-bib-0042){ref-type="ref"}, [43](#bjs538-bib-0043){ref-type="ref"}, [44](#bjs538-bib-0044){ref-type="ref"}, [45](#bjs538-bib-0045){ref-type="ref"}, [46](#bjs538-bib-0046){ref-type="ref"}, 21 analysed cyst size[5](#bjs538-bib-0005){ref-type="ref"} [7](#bjs538-bib-0007){ref-type="ref"}, [8](#bjs538-bib-0008){ref-type="ref"}, [9](#bjs538-bib-0009){ref-type="ref"} [14](#bjs538-bib-0014){ref-type="ref"}, [15](#bjs538-bib-0015){ref-type="ref"} [18](#bjs538-bib-0018){ref-type="ref"}, [20](#bjs538-bib-0020){ref-type="ref"} [23](#bjs538-bib-0023){ref-type="ref"}, [25](#bjs538-bib-0025){ref-type="ref"} [27](#bjs538-bib-0027){ref-type="ref"}, [28](#bjs538-bib-0028){ref-type="ref"} [31](#bjs538-bib-0031){ref-type="ref"}, [36](#bjs538-bib-0036){ref-type="ref"} [38](#bjs538-bib-0038){ref-type="ref"}, [40](#bjs538-bib-0040){ref-type="ref"} [41](#bjs538-bib-0041){ref-type="ref"}, [43](#bjs538-bib-0043){ref-type="ref"} [47](#bjs538-bib-0047){ref-type="ref"}, [48](#bjs538-bib-0048){ref-type="ref"}, [49](#bjs538-bib-0049){ref-type="ref"}, 17 assessed CA19‐9 increase[14](#bjs538-bib-0014){ref-type="ref"} [15](#bjs538-bib-0015){ref-type="ref"}, [18](#bjs538-bib-0018){ref-type="ref"} [21](#bjs538-bib-0021){ref-type="ref"}, [23](#bjs538-bib-0023){ref-type="ref"} [26](#bjs538-bib-0026){ref-type="ref"}, [32](#bjs538-bib-0032){ref-type="ref"} [35](#bjs538-bib-0035){ref-type="ref"}, [38](#bjs538-bib-0038){ref-type="ref"} [43](#bjs538-bib-0043){ref-type="ref"}, [50](#bjs538-bib-0050){ref-type="ref"}, [51](#bjs538-bib-0051){ref-type="ref"}, [52](#bjs538-bib-0052){ref-type="ref"}, [53](#bjs538-bib-0053){ref-type="ref"}, [54](#bjs538-bib-0054){ref-type="ref"}, [55](#bjs538-bib-0055){ref-type="ref"}, [56](#bjs538-bib-0056){ref-type="ref"} and 12 investigated the impact of increased bilirubin levels and/or jaundice[8](#bjs538-bib-0008){ref-type="ref"} [15](#bjs538-bib-0015){ref-type="ref"}, [18](#bjs538-bib-0018){ref-type="ref"} [21](#bjs538-bib-0021){ref-type="ref"}, [31](#bjs538-bib-0031){ref-type="ref"} [38](#bjs538-bib-0038){ref-type="ref"}, [43](#bjs538-bib-0043){ref-type="ref"} [44](#bjs538-bib-0044){ref-type="ref"}, [50](#bjs538-bib-0050){ref-type="ref"} [54](#bjs538-bib-0054){ref-type="ref"}, [57](#bjs538-bib-0057){ref-type="ref"} [58](#bjs538-bib-0058){ref-type="ref"}. Other characteristics (age[13](#bjs538-bib-0013){ref-type="ref"}, [14](#bjs538-bib-0014){ref-type="ref"}, [15](#bjs538-bib-0015){ref-type="ref"} [23](#bjs538-bib-0023){ref-type="ref"}, [27](#bjs538-bib-0027){ref-type="ref"}, carcinoembryonic antigen (CEA) increase[19](#bjs538-bib-0019){ref-type="ref"} [50](#bjs538-bib-0050){ref-type="ref"}, [56](#bjs538-bib-0056){ref-type="ref"}, diabetes mellitus[38](#bjs538-bib-0038){ref-type="ref"} [40](#bjs538-bib-0040){ref-type="ref"}, [48](#bjs538-bib-0048){ref-type="ref"}, lymphadenopathy[6](#bjs538-bib-0006){ref-type="ref"} [32](#bjs538-bib-0032){ref-type="ref"}, [41](#bjs538-bib-0041){ref-type="ref"} [54](#bjs538-bib-0054){ref-type="ref"}, [58](#bjs538-bib-0058){ref-type="ref"}, male sex[18](#bjs538-bib-0018){ref-type="ref"} [23](#bjs538-bib-0023){ref-type="ref"}, [54](#bjs538-bib-0054){ref-type="ref"}, pancreatitis[15](#bjs538-bib-0015){ref-type="ref"} [20](#bjs538-bib-0020){ref-type="ref"}, [31](#bjs538-bib-0031){ref-type="ref"} [35](#bjs538-bib-0035){ref-type="ref"}, [59](#bjs538-bib-0059){ref-type="ref"}, [60](#bjs538-bib-0060){ref-type="ref"}, [61](#bjs538-bib-0061){ref-type="ref"}, thickened cyst wall[6](#bjs538-bib-0006){ref-type="ref"} [8](#bjs538-bib-0008){ref-type="ref"}, [32](#bjs538-bib-0032){ref-type="ref"} [62](#bjs538-bib-0062){ref-type="ref"} and weight loss[10](#bjs538-bib-0010){ref-type="ref"} [57](#bjs538-bib-0057){ref-type="ref"}, [63](#bjs538-bib-0063){ref-type="ref"} [64](#bjs538-bib-0064){ref-type="ref"}) were assessed in between three and seven studies. The characteristics of included studies are shown in Table   [1](#bjs538-tbl-0001){ref-type="table-wrap"}.

![Flow chart depicting the search strategy](BJS5-2-13-g001){#bjs538-fig-0001}

###### 

Characteristics of included studies

  Reference                                                                    Factor                Cut‐off value    No. of patients    Age (years)[\*](#bjs538-note-0001){ref-type="fn"}         Male sex (%)                                 Study type                            Statistical analysis   Type of IPMN
  ---------------------------------------------------------------- ------------------------------- ----------------- ------------------ --------------------------------------------------- -------------------------- ------------------------------------------------------------- ---------------------- --------------
  Baiocchi *et al*.[53](#bjs538-bib-0053){ref-type="ref"}                      CA19‐9                 37 units/ml            44                            69·3 (38--86)                               45·5                         Prospective uncontrolled case study                       Uni              BD+MI+MD
  Hwang *et al*.[52](#bjs538-bib-0052){ref-type="ref"}                         CA19‐9                 37 units/ml           118                         63·4(8·5) (41--85)                              61                                         RCCS                                       Uni                 BD
  Roch *et al*.[55](#bjs538-bib-0055){ref-type="ref"}                          CA19‐9                 37 units/ml           171                             IPMA: 68·4                              IPMA: 80·2                                     RCCS                                      Multi             BD+MI+MD
  IPMC: 71·2                                                                 IPMC: 53·8                                                                                                                                                                                                                     
  Xu *et al*.[51](#bjs538-bib-0051){ref-type="ref"}                            CA19‐9                 37 units/ml            86                           62(9) (41--76)                               72·1                                        RCCS                                       Uni              BD+MI+MD
  Jang *et al*.[47](#bjs538-bib-0047){ref-type="ref"}                         Cyst size                  20 mm              138                         60·6(8·9) (32--82)                              63                                         RCCS                                      Multi             BD+MI+MD
  Nagai *et al*.[49](#bjs538-bib-0049){ref-type="ref"}                        Cyst size                  30 mm               69                                63(9)                                   62·3                                        RCCS                                       Uni                 BD
  Akita *et al*.[17](#bjs538-bib-0017){ref-type="ref"}                           MN                       --                 32                           IPMA: 65·3(8·5)                            IPMA: 65                                      RCCS                                      Multi                BD
  IPMC: 62·6(7·5)                                                             IPMC: 50                                                                                                                                                                                                                      
  Arima *et al*.[29](#bjs538-bib-0029){ref-type="ref"}                           MN                       --                 76                           IPMA: 66·3(8·3)                            IPMA: 72                                      RCCS                                       Uni              BD+MI+MD
  IPMC: 70·3(9·1)                                                            IPMC: 65·4                                                                                                                                                                                                                     
  Kawada *et al*.[24](#bjs538-bib-0024){ref-type="ref"}                          MN                      10 mm              202                                68(7)                                   54·5                                        RCCS                                      Multi                BD
  Kwong *et al*.[33](#bjs538-bib-0033){ref-type="ref"}                           MN                       --                284                             67·3(10·8)                                  43                     Retrospective multicentre case--control study                  Uni                 BD
  Moris *et al*.[34](#bjs538-bib-0034){ref-type="ref"}                           MN                       --                856                                70·6                                     39              Retrospective international multicentre case--control study           Uni                 BD
  Ogawa *et al*.[11](#bjs538-bib-0011){ref-type="ref"}                           MN                    \> 3·6 mm             49                            64·9 (41--81)                               66·1                                        RCCS                                       Uni                 BD
  Ohno *et al*.[12](#bjs538-bib-0012){ref-type="ref"}                         MN on EUS                   --                 87                              66·5(9·5)                                 60·9                                        RCCS                                       Uni              BD+MI+MD
  Seo *et al*.[37](#bjs538-bib-0037){ref-type="ref"}                             MN                       --                 60                               64·3(9)                                  63·3                                        RCCS                                      Multi                BD
  Shimizu *et al*.[22](#bjs538-bib-0022){ref-type="ref"}                         MN                      7 mm               310                              67·1(8·7)                                 58·3                                        RCCS                                      Multi             BD+MI+MD
  Kang *et al*.[45](#bjs538-bib-0045){ref-type="ref"}                            MPD                     7 mm               375                              63·8(9·0)                                 62·4                                        RCCS                                      Multi             BD+MI+MD
  Ridtitid *et al*.[46](#bjs538-bib-0046){ref-type="ref"}                        MPD                    5--9 mm             105                             65·2(12·5)                                  53                                         RCCS                                       Uni                 BD
  Sadakari *et al*.[39](#bjs538-bib-0039){ref-type="ref"}                        MPD                     5 mm                73                           66(8) (46--82)                               65·8                                        RCCS                                       Uni                 BD
  Ohno *et al*.[42](#bjs538-bib-0042){ref-type="ref"}                  MPD enlargement on EUS             --                142                           65(9) (37--83)                               53·8                                        RCCS                                       Uni                 BD
  Kim et al. [59](#bjs538-bib-0059){ref-type="ref"}                         Pancreatitis                  --                118                            61·2 (37--78)                               70·3                                        RCCS                                       Uni              BD+MI+MD
  Morales‐Oyarvide et al. [61](#bjs538-bib-0061){ref-type="ref"}            Pancreatitis                  --                325                              68(10·9)                                  48·9                                        RCCS                                      Multi             BD+MI+MD
  Tsutsumi et al. [60](#bjs538-bib-0060){ref-type="ref"}                    Pancreatitis                  --                150                     Pancreatitis group: 70(8·2)              Pancreatitis group: 57·9                              RCCS                                       Uni              BD+MI+MD
  Non‐pancreatitis group: 66(8·6)                                   Non‐pancreatitis group: 62·6                                                                                                                                                                                                            
  Carbognin et al. [62](#bjs538-bib-0062){ref-type="ref"}                Thickened cyst wall              --                 29                           IPMA: 64·7(9·9)                              58·6                                        RCCS                                       Uni                 BD
  IPMC: 62·2(12·2)                                                                                                                                                                                                                                                                                          
  Correa‐Gallego et al. [63](#bjs538-bib-0063){ref-type="ref"}               Weight loss                  --                123                             68 (62--75)                                40·7                                        RCCS                                      Multi                BD
  Dortch et al. [64](#bjs538-bib-0064){ref-type="ref"}                       Weight loss                 10 lb               66                               68(8·5)                                 33·36                                        RCCS                                       Uni                 BD
  Ammori et al. [25](#bjs538-bib-0025){ref-type="ref"}                        Cyst size                  30 mm              184                             68 (34--88)                                n.a.                                        RCCS                                       Uni              BD+MI+MD
  MN                                                                                                                                                                                                                                                                                                        
  Chiu et al. [6](#bjs538-bib-0006){ref-type="ref"}                        Lymphadenopathy                                   40                             60 (32--67)                                 69                                         RCCS                                      Multi              BD+MI
  MN                                                                            3 mm                      Uni                                                                                                                                                                                               
  Thickened cyst wall                                                           3 mm                      Uni                                                                                                                                                                                               
  Fritz et al. [50](#bjs538-bib-0050){ref-type="ref"}                          CA19‐9                 37 units/ml           142                                n.a.                                   57·75                                        RCCS                                       Uni              BD+MI+MD
  CEA                                                                          5 ng/ml                    142                                                                                                                                                                                               
  Jaundice (bilirubin)                                                         2 mg/dl                    160                                                                                                                                                                                               
  Fritz et al. [54](#bjs538-bib-0054){ref-type="ref"}                          CA19‐9                 37 units/ml           233                             66 (28--87)                               39·91                                        RCCS                                       Uni                 BD
  Jaundice (bilirubin total)                                                   2 mg/dl                                                                                                                                                                                                                      
  Lymphadenopathy                                                                                                                                                                                                                                                                                           
  Male sex                                                                                                                                                                                                                                                                                                  
  Fujino et al. [38](#bjs538-bib-0038){ref-type="ref"}                         CA19‐9                 35 units/ml            64                            IPMA: 66(1·2)                              60·94                                        RCCS                                      Multi             BD+MI+MD
  Cyst size                                                                     42 mm               IPMC: 65·1(9·5)         Uni                                                                                                                                                                             
  DM                                                                                                      Uni                                                                                                                                                                                               
  Jaundice                                                                       Uni                                                                                                                                                                                                                        
  MPD size                                                                       Uni                                                                                                                                                                                                                        
  Goh et al. [44](#bjs538-bib-0044){ref-type="ref"}                    Jaundice (obstructive)                                39                             63 (33--83)                                 66                                         RCCS                                       Uni                 BD
  MPD                                                                           5 mm                                                                                                                                                                                                                        
  Hirono et al. [13](#bjs538-bib-0013){ref-type="ref"}                           Age                   70 years              54                             69 (44--81)                                57·4                                        RCCS                                       Uni              BD+MI+MD
  MN                                                                            5 mm                                                                                                                                                                                                                        
  Hirono et al. [21](#bjs538-bib-0021){ref-type="ref"}                         CA19‐9                 37 units/ml           134                          68(9·7) (32--84)                              55·2                                        RCCS                                       Uni                 BD
  Jaundice (obstructive)                                                                                  Uni                                                                                                                                                                                               
  MN                                                                            5 mm                     Multi                                                                                                                                                                                              
  MPD                                                                           5 mm                      Uni                                                                                                                                                                                               
  Hwang et al. [19](#bjs538-bib-0019){ref-type="ref"}                            CEA                    5 ng/ml             237                            63·1 (38--83)                               57·8                                        RCCS                                      Multi                BD
  MN                                                                                                      237                                                                                                                                                                                               
  Jang et al. [26](#bjs538-bib-0026){ref-type="ref"}                           CA19‐9                 37 units/ml           333                              63·6(8·9)                                 61·7                                        RCCS                                      Multi                BD
  MN                                                                                                      350                                                                                                                                                                                               
  MPD                                                                           5 mm                      350                                                                                                                                                                                               
  Kato et al. [27](#bjs538-bib-0027){ref-type="ref"}                             Age                   65 years              47                            66·2 (50--77)                               63·8                                        RCCS                                       Uni                 BD
  Cyst size (enlargement)                                                                                 17                Uni                                                                                                                                                                             
  MN                                                                                                      47               Multi                                                                                                                                                                            
  MPD                                                                           5 mm                      47                Uni                                                                                                                                                                             
  Kim et al. [32](#bjs538-bib-0032){ref-type="ref"}                            CA19‐9                 37 units/ml           367                               63·7(9)                                   63                                         RCCS                                      Multi             BD+MI+MD
  Lymphadenopathy                                                                                         Uni                                                                                                                                                                                               
  MN                                                                                                     Multi                                                                                                                                                                                              
  MPD                                                                           5 mm                     Multi                                                                                                                                                                                              
  Thickened cyst wall                                                                                     Uni                                                                                                                                                                                               
  Kim et al. [30](#bjs538-bib-0030){ref-type="ref"}                              MN                      10 mm               93                                n.a.                                    n.a.                                        RCCS                                       Uni              BD+MI+MD
  MPD                                                                            --                                                                                                                                                                                                                         
  Kim et al. [18](#bjs538-bib-0018){ref-type="ref"}                            CA19‐9                 37 units/ml           324                             62 (30--83)                                55·2                                        RCCS                                      Multi                BD
  Cyst size                                                                                               324               Uni                                                                                                                                                                             
  Jaundice (bilirubin)                                                        1·2 mg/dl                   187               Uni                                                                                                                                                                             
  Male sex                                                                                                324              Multi                                                                                                                                                                            
  MN                                                                            5 mm                      324              Multi                                                                                                                                                                            
  MPD                                                                                                     324              Multi                                                                                                                                                                            
  Kim et al. [31](#bjs538-bib-0031){ref-type="ref"}                           Cyst size                  30 mm              177                             63 (30--87)                                 61                     Retrospective multicentre case--control study                  Uni                 BD
  Jaundice (obstructive)                                                                                  177               Uni                                                                                                                                                                             
  MN on EUS                                                                     5 mm                      110                                                                                                                                      Multi                                                    
  Pancreatitis                                                                                            177                                                                                                                                       Uni                                                     
  Kurahara et al. [35](#bjs538-bib-0035){ref-type="ref"}                         MN                      5 mm                55                           IPMA: 64·8(9·2)                              67·3                                        RCCS                                      Multi                BD
  Pancreatitis                                                                                      IPMC: 63·4(8·8)                                                                                                                                                                                         
  CA19‐9                                                                     37 units/ml                                                                                                                                                                                                                    
  Lee et al. [41](#bjs538-bib-0041){ref-type="ref"}                           Cyst size                  40 mm              129                            60·9 (32--77)                               72·9                                        RCCS                                       Uni              BD+MI+MD
  Lymphadenopathy                                                                                        Multi                                                                                                                                                                                              
  MPD                                                                           7 mm                     Multi                                                                                                                                                                                              
  Lou et al. [57](#bjs538-bib-0057){ref-type="ref"}                           Jaundice                    --                 51                             63 (41--78)                                64·7                                        RCCS                                       Uni              BD+MI+MD
  Weight loss                                                                                                                                                                                                                                                                                               
  Maguchi et al. [16](#bjs538-bib-0016){ref-type="ref"}                          MN                       --                 29                             66 (37--85)                                51·3                    Retrospective multicentre case--control study                  Uni                 BD
  MPD dilated + MN                                                                                                                                                                                                                                                                                          
  Mimura et al. [40](#bjs538-bib-0040){ref-type="ref"}                        Cyst size                  30 mm               43                           IPMA: 66(1·84)                               67·4                                        RCCS                                       Uni              BD+MI+MD
  DM                                                                                                      82          IPMC: 66·7(1·86)                         Multi                                                                                                                                        
  MPD                                                                           6 mm                      43                Uni                                                                                                                                                                             
  Murakami et al. [7](#bjs538-bib-0007){ref-type="ref"}                       Cyst size                  28 mm               62                                n.a.                                 IPMA: 79·5                                     RCCS                                       Uni              BD+MI+MD
  MN                                                                                                  IPMC: 65·3            Uni                                                                                                                                                                             
  MPD                                                                           6 mm                     Multi                                                                                                                                                                                              
  Nagai et al. [10](#bjs538-bib-0010){ref-type="ref"}                            MN                       --                 57                          IPMA: 63 (46--80)                          IPMA: 46·4                                     RCCS                                       Uni               BD+MI
  Weight loss                                                             IPMC: 64 (41--85)           IPMC: 65·5                                                                                                                                                                                            
  Nara et al. [14](#bjs538-bib-0014){ref-type="ref"}                             Age                   70 years             123                            64·7 (40--84)                               56·9                                        RCCS                                       Uni              BD+MI+MD
  CA19‐9                                                                     37 units/ml                                   Multi                                                                                                                                                                            
  Cyst size                                                                     40 mm                    Multi                                                                                                                                                                                              
  MN                                                                                                     Multi                                                                                                                                                                                              
  Ohtsuka et al. [20](#bjs538-bib-0020){ref-type="ref"}                       Cyst size                  30 mm               99                             67 (33--85)                             IPMA: 57·1                                     RCCS                                       Uni                 BD
  MN                                                                         IPMC: 75·7                  Multi                                                                                                                                                                                              
  Pancreatitis                                                                  Multi                                                                                                                                                                                                                       
  Okabayashi et al. [5](#bjs538-bib-0005){ref-type="ref"}                     Cyst size                  30 mm               23                            66·4 (53--86)                               69·6                                        RCCS                                      Multi             BD+MI+MD
  MN on EUS                                                                     5 mm                      10                                                                                                                                                                                                
  Rodriguez et al. [8](#bjs538-bib-0008){ref-type="ref"}                      Jaundice                                      145                             67 (35--90)                                42·8                                        RCCS                                       Uni                 BD
  MN                                                                                                                                                                                                                                                                                                        
  Thickened cyst wall                                                                                                                                                                                                                                                                                       
  Cyst size                                                                     30 mm                                                                                                                                                                                                                       
  Sahora et al. [23](#bjs538-bib-0023){ref-type="ref"}                           Age                   65 years             217                             67 (21--92)                                37·8                                        RCCS                                      Multi                BD
  CA19‐9                                                                     39 units/ml                                                                                                                                                                                                                    
  Cyst size                                                                     30 mm                                                                                                                                                                                                                       
  Male sex                                                                                                                                                                                                                                                                                                  
  MN                                                                                                                                                                                                                                                                                                        
  MPD                                                                           5 mm                                                                                                                                                                                                                        
  Shin et al. [15](#bjs538-bib-0015){ref-type="ref"}                             Age                   60 years             204                             61 (35--77)                                68·1                                        RCCS                                      Multi             BD+MI+MD
  CA19‐9                                                                     37 units/ml                 Multi                                                                                                                                                                                              
  Cyst size                                                                     30 mm                     Uni                                                                                                                                                                                               
  Jaundice (bilirubin)                                                        1·2 mg/dl                   Uni                                                                                                                                                                                               
  MN                                                                                                     Multi                                                                                                                                                                                              
  MPD                                                                           6 mm                     Multi                                                                                                                                                                                              
  Pancreatitis                                                                                           Multi                                                                                                                                                                                              
  Suzuki et al. [36](#bjs538-bib-0036){ref-type="ref"}                        Cyst size                  47 mm               96                           67(10) (34--81)                              66·7                                        RCCS                                      Multi             BD+MI+MD
  MN                                                                            9 mm                                                                                                                                                               Multi                                                    
  MPD                                                                           9 mm                                                                                                                                                                Uni                                                     
  Takeshita et al. [9](#bjs538-bib-0009){ref-type="ref"}            Cyst size + MPD max. diameter         --                 46                             65 (43--78)                                52·8                                        RCCS                                      Multi                BD
  MN                                                                             Uni                                                                                                                                                                                                                        
  MPD dilated + max. cyst size                                                  Multi                                                                                                                                                                                                                       
  Walter et al. [28](#bjs538-bib-0028){ref-type="ref"}                           MN                      30 mm               60                              64(12·2)                                  60·3                                        RCCS                                      Multi             BD+MI+MD
  Cyst size                                                                                                                                                                                                                                                                                                 
  Woo et al. [48](#bjs538-bib-0048){ref-type="ref"}                           Cyst size                  30 mm               85                             63 (40--82)                                58·8                                        RCCS                                       Uni                 BD
  DM                                                                                                                                                                                                                                                                                                        
  Xu et al. [43](#bjs538-bib-0043){ref-type="ref"}                             CA19‐9                 37 units/ml            54                      IPMA: 61·4(8·24) (43--81)                         66·7                                        RCCS                                      Multi             BD+MI+MD
  Cyst size                                                                     30 mm                     Uni                                                                                                                                                                                               
  Jaundice                                                                       Uni                                                                                                                                                                                                                        
  MPD                                                                            Uni                                                                                                                                                                                                                        
  Yamada et al. [58](#bjs538-bib-0058){ref-type="ref"}                 Jaundice (obstructive)             --                166                              66·6(8·5)                                 60·2                                        RCCS                                      Multi             BD+MI+MD
  Lymphadenopathy                                                                                                                                                                                                                                                                                           
  You et al. [56](#bjs538-bib-0056){ref-type="ref"}                            CA19‐9                 37 units/ml            87                              61·5(9·2)                                 64·4                                        RCCS                                      Multi             BD+MI+MD
  CEA                                                                          5 ng/ml                                                                                                                                                                                                                      

Values are mean(s.d.) (range). IPMN, intraductal papillary mucinous neoplasia; CA, carbohydrate antigen; Uni, univariable; BD, branch duct; MI, mixed‐type IPMN; MD, main duct; RCCS, retrospective controlled cohort study; IPMA, benign IPMN; IPMC, malignant IPMN; Multi, multivariable; MN, mural nodules; EUS, endoscopic ultrasonography; MPD, main pancreatic duct; n.a., not available; CEA, carcinoembryonic antigen.

AUC values derived from HSROC curves were calculated for each factor (*Table*   [2](#bjs538-tbl-0002){ref-type="table-wrap"}). The largest AUCs were 0·84 for weight loss (*Fig*.  [2](#bjs538-fig-0002){ref-type="fig"}) and 0·80 for jaundice (*Fig*.  [3](#bjs538-fig-0003){ref-type="fig"}), followed by the serological markers CEA (0·79) and CA19‐9 (0·78) (*Fig*.  [3](#bjs538-fig-0003){ref-type="fig"}). The radiological criteria of lymphadenopathy (0·51) and thickened cyst wall (0·56) had the lowest AUC values (*Fig*. [4](#bjs538-fig-0004){ref-type="fig"}).

###### 

Results of the pooled analysis

                         No. of studies   No. of patients  AUC                 Sensitivity (%)   Specificity (%)   DOR                   *I* ^2^ (%)
  --------------------- ---------------- ----------------- ------------------- ----------------- ----------------- -------------------- -------------
  Age                          5                645        0·67 (0·62, 0·72)   71 (53, 89)       59 (47, 71)       3·64 (2·20, 6·03)         21
  CA19‐9                       17              2747        0·78 (0·75, 0·82)   49 (41, 57)       89 (86, 92)       7·29 (5·36, 9·91)         44
  CEA                          3                456        0·79 (0·70, 0·86)   35 (21, 48)       95 (91, 99)       8·37 (4·27, 16·42)         0
  Cyst size                    21              2375        0·68 (0·65, 0·72)   64 (56, 72)       69 (61, 77)       3·62 (2·75, 4·76)         35
  Diabetes                     3                231        0·71 (0·62, 0·79)   46 (37, 56)       83 (76, 90)       4·42 (2·20, 8·90)          0
  Jaundice                     12              1689        0·80 (0·76, 0·84)   26 (18, 33)       97 (96, 99)       7·98 (5·24, 12·15)         0
  Lymphadenopathy              5                945        0·51 (0·41, 0·61)   20 (8, 32)        93 (84, 100)      4·74 (2·18, 11·14)        52
  Male sex                     3                774        0·62 (0·56, 0·68)   59 (48, 71)       59 (47, 71)       2·14 (1·47, 3·12)          0
  Dilatation of MPD            21              2991        0·77 (0·73, 0·80)   60 (52, 68)       80 (75, 86)       6·59 (4·69, 9·26)         55
  Mural nodules                33              5068        0·77 (0·75, 0·80)   65 (60, 71)       81 (76, 85)       7·89 (6·34, 9·82)         32
  Pancreatitis                 7               1127        0·67 (0·63, 0·72)   32 (21, 43)       86 (80, 91)       2·67 (1·94, 3·68)          2
  Thickened cyst wall          4                581        0·56 (0·46, 0·66)   23 (10, 36)       95 (88, 100)      4·93 (1·98, 11·35)        11
  Weight loss                  4                297        0·84 (0·78, 0·89)   53 (34, 72)       90 (83, 96)       8·72 (4·21, 18·07)         0

Values in parentheses are 95 per cent confidence intervals. AUC, area under the curve; DOR, diagnostic odds ratio; CA, carbohydrate antigen; CEA, carcinoembryonic antigen; MPD, main pancreatic duct.

![Receiver operating characteristic (ROC) curves for clinical parameters associated with malignancy in intraductal papillary mucinous neoplasia: **a** pancreatitis, **b** weight loss, **c** male sex, **d** age, **e** diabetes mellitus](BJS5-2-13-g002){#bjs538-fig-0002}

![Receiver operating characteristic (ROC) curves for serological parameters associated with malignancy in intraductal papillary mucinous neoplasia: **a** carbohydrate antigen (CA) 19‐9, **b** jaundice, **c** carcinoembryonic antigen (CEA)](BJS5-2-13-g003){#bjs538-fig-0003}

![Receiver operating characteristic (ROC) curves for radiological parameters associated with malignancy in intraductal papillary mucinous neoplasia: **a** dilatation of main pancreatic duct (MPD), **b** thickened cyst wall, **c** mural nodules, **d** lymphadenopathy, **e** cyst size](BJS5-2-13-g004){#bjs538-fig-0004}

Factors with the highest sensitivities were patient age (71 per cent), presence of mural nodules (65 per cent) and cyst size (64 per cent). Jaundice (26 per cent), thickened cyst wall (23 per cent) and lymphadenopathy (20 per cent) were the least sensitive. Specificity was highest for jaundice (97 per cent), raised CEA level (95 per cent) and thickened cyst wall (95 per cent), and lowest for patient age (59 per cent) and male sex (59 per cent) (*Table*   [2](#bjs538-tbl-0002){ref-type="table-wrap"}; *Fig.*  [S1](#bjs538-supitem-0001){ref-type="supplementary-material"}, supporting information). Jaundice (82 per cent) and lymphadenopathy (71 per cent) had the highest PPVs, and male sex the lowest (26 per cent); NPVs ranged from 86 per cent for male sex to 60 per cent for diabetes mellitus (*Fig. * [S1](#bjs538-supitem-0001){ref-type="supplementary-material"}, supporting information).

The pooled DOR was highest for weight loss (8·72), CEA increase (8·37) and jaundice (7·98), and lowest for male sex (2·14) and pancreatitis (2·67) (*Table*   [2](#bjs538-tbl-0002){ref-type="table-wrap"}; *Figs S2--S4*, supporting information).

Analysis of heterogeneity of the included factors revealed low heterogeneity for the majority (below 30 per cent), with moderate heterogeneity (30--60 per cent) for CA19‐9 level, cyst size, lymphadenopathy, dilatation of the MPD and the presence of mural nodules (*Table*   [2](#bjs538-tbl-0002){ref-type="table-wrap"}). Funnel plots of study quality are shown in *Fig. S5* (supporting information).

Discussion {#bjs538-sec-0008}
==========

High reliability in the identification or exclusion of malignancy is an important characteristic of a diagnostic test that is clinically useful in patients with suspected cancer. This meta‐analysis assessed the diagnostic accuracy of a number of established clinical, radiological and serological markers, and revealed that no single clinically established factor (or the absence of such a factor) sufficiently predicted or excluded malignancy. Several factors provided high specificity, but sensitivity was generally poor.

Although it provides a comprehensive overview of all established factors in the stratification of IPMN of the pancreas, this analysis has several limitations. Studies evaluating BD, MD and mixed‐type IPMN were all included. It is conceded that many surgeons would feel that MD IPMN should generally be resected and might wonder why those different entities were investigated in one analysis. Although the dogma that all MD IPMN should be resected is based on an estimated malignancy rate of 61·6 per cent, compared with only 25·5 per cent for BD IPMN[2](#bjs538-bib-0002){ref-type="ref"}, IPMN with only minimal MD involvement can be followed up safely without surgical intervention in some patients[65](#bjs538-bib-0065){ref-type="ref"}. On the other hand, BD IPMN with high‐risk signs according to the Fukuoka consensus should be resected[2](#bjs538-bib-0002){ref-type="ref"}. Future biomarkers might provide safe exclusion of malignancy in MD and BD IPMN. Until such reliable biomarkers have been established, the risk of malignancy in MD IPMN, mixed‐type IPMN and BD IPMN might be estimated incorrectly. The authors chose to include all three subtypes of IPMN of the pancreas to gain a thorough overview of the current literature, although it is accepted that this approach might represent a source of bias. Other limitations include the retrospective nature of most of the included studies, the conversion of continuous variables into binary variables, and heterogeneity of the studies.

The absence of a single valid criterion to predict malignancy leads to the conclusion that several factors need to be combined to identify sufficiently patients likely to benefit from intervention, or observation. The presence or absence of combinations of factors including jaundice, presence of mural nodules, dilatation of the MPD and others might then be used to guide treatment decisions.

The present study did identify factors with relatively high AUCs, such as the presence of increased levels of tumour markers. CEA and CA19‐9 are not included in the recommendations of the current consensus guidelines, but they might be valuable adjuncts where there is diagnostic uncertainty owing to their relatively high specificity. Several potential scoring formulas to improve diagnostic accuracy have been developed over the past decade[19](#bjs538-bib-0019){ref-type="ref"} [36](#bjs538-bib-0036){ref-type="ref"}, [66](#bjs538-bib-0066){ref-type="ref"} [67](#bjs538-bib-0067){ref-type="ref"}, but none has been validated prospectively.

Until the identification of biomarkers with an adequate ROC curve (such as troponin T for the diagnosis of myocardial infarction), decisions regarding intervention or observation remain largely dependent on the 'gut feeling' of treating clinicians. An international prospective study using highly standardized clinical pathways with the collection of high‐quality biomaterial should be undertaken.
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